<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39327799</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-3673</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of leukocyte biology</Title><ISOAbbreviation>J Leukoc Biol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 extracellular vesicles display heterogeneity based on viral and host RNA expression: implications for host immune response.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">qiae212</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jleuko/qiae212</ELocationID><Abstract><AbstractText>Viral RNA and miRNAs released by immune cells contribute to inflammation in COVID-19 patients. Here, we investigated the role of SARS-CoV2 RNA and host miRNAs carried within extracellular vesicles (EVs) in modulating inflammation. EVs were classified as positive or negative depending on their viral RNA cargo. To assess the function of viral RNA, EVs, and LPS were used to stimulate whole blood samples from healthy subjects, and the secretion of 27 serum analytes was measured. EVs alone did not induce cytokines, chemokines, or growth factors. However, under LPS stimulation, (SARS-CoV2+) EVs increased IL-12 and decreased IL-13 secretion, while (SARS-CoV2-) EVs increased MIP-1α and IL-1β secretion. Host miR-19a-3p, -192-5p, -let-7c-5p, and -92b-3a were differentially expressed in association with viral RNA. EVs from COVID-19 patients exhibited differences in viral RNA and miRNA expression profiles that modulate LPS responses. This knowledge sheds light on the immunopathology of COVID-19.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Society for Leukocyte Biology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Juárez</LastName><ForeName>Esmeralda</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9036-004X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vázquez-Pérez</LastName><ForeName>Joel A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Biology of Emergent Diseases and COPD, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carreto-Binaghi</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0003-0356-4138</Identifier><AffiliationInfo><Affiliation>Laboratory of Immunobiology of Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Sanabria</LastName><ForeName>Claudia A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado-Cantú</LastName><ForeName>Manuel G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarabia</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0000-4006-5675</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>María Teresa</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0001-7941-5468</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzmán-Beltrán</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7491-1910</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutiérrez-González</LastName><ForeName>Luis H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0003-0708-0448</Identifier><AffiliationInfo><Affiliation>Laboratory of Transcriptomics and Molecular Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Leukoc Biol</MedlineTA><NlmUniqueID>8405628</NlmUniqueID><ISSNLinking>0741-5400</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39327799</ArticleId><ArticleId IdType="doi">10.1093/jleuko/qiae212</ArticleId><ArticleId IdType="pii">7778320</ArticleId></ArticleIdList></PubmedData></PubmedArticle>